You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)

Article metrics

Article menu

Download PDFPDF

XML
Clinical Care/Education/Nutrition
Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)

 

Online download statistics by month:

Online download statistics by month: February 2018 to March 2024

AbstractFullPdf
Feb 201827024953
Mar 201847047780
Apr 201810310332
May 201813314020
Jun 20189810025
Jul 201813313333
Aug 201810010036
Sep 2018979752
Oct 2018959564
Nov 2018949434
Dec 201817617654
Jan 201913413336
Feb 2019767478
Mar 2019100100135
Apr 2019929076
May 2019616178
Jun 20199290108
Jul 20198890118
Aug 2019737379
Sep 20197171136
Oct 20199293100
Nov 2019939371
Dec 2019808047
Jan 2020848430
Feb 2020393990
Mar 2020606076
Apr 2020403944
May 2020313154
Jun 2020343339
Jul 2020444126
Aug 2020272626
Sep 2020696357
Oct 2020595950
Nov 2020726858
Dec 2020858035
Jan 2021413934
Feb 2021666246
Mar 2021696727
Apr 2021494630
May 2021747320
Jun 2021474722
Jul 2021434318
Aug 2021434138
Sep 2021423823
Oct 2021484530
Nov 2021676023
Dec 2021616014
Jan 202239464
Feb 202222227
Mar 2022525219
Apr 2022848319
May 2022777926
Jun 2022949840
Jul 2022666416
Aug 2022767418
Sep 2022999618
Oct 202210410114
Nov 202211210516
Dec 2022545516
Jan 2023585710
Feb 2023838411
Mar 2023747413
Apr 2023595921
May 2023575412
Jul 202355574
Aug 202347489
Sep 202349516
Oct 2023737810
Nov 202392951
Dec 202348475
Jan 2024232210
Feb 202458537
Mar 202412412889
Total589458382876